Pakistan's Children at Risk: TB Drug Shortage Sparks Crisis

The Pakistan Medical Association (PMA) has issued a severe national alert regarding a critical shortage of essential paediatric tuberculosis (TB) medications. This alarming scarcity, reported across healthcare facilities nationwide, signals a potential 'catastrophic surge' in drug-resistant TB among Pakistan's children.

The association attributes this crisis to a near-total depletion of first-line paediatric TB drugs, indicating a significant breakdown in the National TB Programme's (NTP) mandate to ensure treatment availability. The persistent interruption of medication is hazardous, increasing the risk of multi-drug resistant (MDR) and extensively drug-resistant (XDR) TB.

Children are particularly susceptible to the consequences of inconsistent treatment. Without proper medication, the risk of disseminated TB, where infection spreads to vital organs, escalates. If first-line drugs fail, children may face lengthy, toxic second-line treatments with severe side effects like liver toxicity and hearing loss.

The shortage stems from complex issues, including companies halting production due to frozen retail price caps that made raw material costs unviable, leading to import reliance. While some deregulated medicines have returned, paediatric formulations remain critically scarce due to ongoing procurement and distribution failures within the NTP and the federal health ministry's management unit.

To avert a public health disaster, the PMA urges immediate emergency imports of paediatric TB formulations. They call for accountability of the NTP for supply chain failures and demand transparent audits of drug stocks for equitable distribution, emphasizing the need for federal and provincial intervention before the shortage becomes an unmanageable national health crisis.